> Neutron is almost complete...
I've made hundreds of thousands of dollars from my early investments in RKLB but this isn't true if by "complete" you mean they have a proven launch vehicle. The company is now targeting late 2026 for Neutron's inaugural flight.
Neutron was announced in 2021. There were hopes for a 2024 first flight. Then it was mid-to-late 2025. Now it's Q4 2026 after a failure related to the stage 1 tank earlier this year.
If anyone can pull off using carbon composite for a launch vehicle of this size, it's RKLB. But nobody has done it before and I think the retail investor base is taking for granted something that is not at all guaranteed. There's much more risk than a lot of people think.
In some ways, RKLB is more like pre-clinical biotech stocks, which usually produce binary outcomes (a drug succeeds or it fails, and the company's fate is based on that). If Neutron works, RKLB gets to execute its grand vision. If it fails, it doesn't. The vision (and valuation) doesn't work without Neutron.
Yes tho I'd argue that Rocket Lab has the finances to easily weather a few more years of Neutron set back if that ends up happening (fingers crossed it doesn't happen). They aren't going bust anytime soon. So I don't see the downside as being zero.